Efficacy and Safety of Jiannao Tongluo Granules in Motor Dysfunction After Cerebral Infarction: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Hubei Provincial Hospital of Integrated Chinese and Western Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. It meets the diagnostic criteria of cerebral infarction and is confirmed by head CT or MRI;
•2. Comply with the standard of stroke-wind, phlegm and blood stasis syndrome in traditional Chinese medicine;
•3. In the recovery period (the course of illness is 2 weeks to 6 months);
•4. Aged 40 to 75 years;
•5. For the first time, the vital signs are stable, the consciousness is clear, and they can cooperate with the examination and treatment;
•6. There is obvious motor dysfunction, Fugl-Meyer score <=84 points;
•7. Volunteer to participate in this study and sign an informed consent form.

•1. Patients with severe cardiovascular, cerebrovascular, liver, kidney, malignant tumors, hematological diseases, and mental illnesses;
•2. Transient organic psychosis and other mental illnesses (such as depression, schizophrenia), or other mental disorders that meet the DSM-IV-R standards;
•3. Those who are allergic to test drug ingredients, or have a history of alcohol or drug abuse;
•4. Women who are pregnant or breastfeeding, or have a pregnancy plan within the past 6 months, or who cannot use effective contraceptive measures (sterilization, long-term use of contraceptives/drugs, condoms, or removal of the vas deferens from their partners, etc.);
•5. Participating in other clinical trials or participating in other drug clinical trials within 3 months;
•6. The investigator judges the patients who are not suitable to participate in this trial.

发起方

Hubei Provincial Hospital of Integrated Chinese and Western Medicine